Apollo Stack vs Nootropic God Stack

A side-by-side research comparison of Apollo Stack and Nootropic God Stack across mechanism, dosing, half-life, benefits, side effects and research status.

Comparison table

Attribute	Apollo Stack	Nootropic God Stack
Full name	Apollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin)	Nootropic God (Semax + Selank + Dihexa + Cerebrolysin)
Category	Popular Stacks	Popular Stacks
Status	Research stack	Research stack
Mechanism	Semaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis.	Semax upregulates BDNF/NGF expression and enhances dopaminergic/serotonergic transmission. Selank modulates GABA and reduces anxiety. Dihexa is a potent HGF/c-Met activator driving synapse formation (10 million times more potent than BDNF at synapses). Cerebrolysin provides a cocktail of neurotrophic factors.
Molecular weight	Multiple compounds	Multiple compounds
Half-life	Semaglutide: ~7 days, 5A1MQ: ~6h, MOTS-c: ~4h, Tesamorelin: ~30min	Semax: ~30min, Selank: ~2min, Dihexa: ~12h, Cerebrolysin: ~4-6h
Bioavailability	Variable by component	Semax/Selank: intranasal ~60%, Dihexa: oral ~70%, Cerebrolysin: IM ~100%
Typical dose	Sema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/day	Semax 600mcg + Selank 400mcg nasal + Dihexa 10mg oral + Cerebrolysin 5ml IM
Frequency	Variable by component	Daily (Cerebrolysin: 10-20 day courses)
Route	SC injection + Oral	Intranasal + Oral + Intramuscular

Apollo Stack reported benefits

Dramatic fat loss
Visceral fat reduction
Metabolic rate increase
Appetite control
Improved insulin sensitivity
Cellular energy boost

Nootropic God Stack reported benefits

Dramatically enhanced focus
Neuroplasticity increase
Memory consolidation
Anxiety reduction
Synaptogenesis
Neuroprotection

Related comparisons

Research and educational reference only. Not medical advice.